2009-11-25 11:39:21 - CNS Therapeutics - A World Market Review - a new market research report on companiesandmarkets.com

www.companiesandmarkets.com/Summary-Market-Report/cns-therapeuti ..

""While the available CNS therapies can slow down deteriorating condition of patient, the clinical pipeline boasts of new drug classes with potential to stop or reverse the disease´s progression. Continuing switch over of patients from typical or traditional anti-psychotics to expensive and safer atypical anti-psychotics drugs, such as Zyprexa, Risperdal and Geodon is driving the market forward. Global market for anti-depressants, a dominant product category of CNS therapeutics is on a decline, succumbed by increasing generic competition, loss of patent protection of key drugs, and increased risk of suicidal tendencies among adolescents.

These and other market data and trends are presented in """"CNS Therapeutics: World Market Review"""" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage

 

 

and vertical market analyses""